Hims & Hers (NYSE: HIMS) CFO sells shares after option exercises

Rhea-AI Filing Summary

Hims & Hers Health, Inc. Chief Financial Officer Oluyemi Okupe reported stock option exercises and a share sale. On January 20, 2026, the CFO exercised stock options for 7,317 Class A Common shares at an exercise price of $5.01 per share and for 1,750 shares at $11.53 per share. That same day, 9,067 Class A Common shares were sold at a weighted average price of $30.3423, with actual sale prices ranging from $30.21 to $30.44.

After these transactions, the CFO directly owned 91,617 Class A Common shares and held stock options covering 149,313 and 42,996 shares in two separate option awards. An additional 7,853 shares were held indirectly through the Oluyemi Okupe Separate Property Trust dated September 1, 2021. The filing states that the option exercises and related sales were carried out under a Rule 10b5-1 trading plan adopted on May 21, 2025, which is a pre-arranged program for trading company stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Okupe Oluyemi

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	01/20/2026		M(1)		7,317	A	$5.01	98,934	D
Class A Common Stock	01/20/2026		M(1)		1,750	A	$11.53	100,684	D
Class A Common Stock	01/20/2026		S		9,067	D	$30.3423(2)	91,617	D
Class A Common Stock								7,853	I	Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$5.01	01/20/2026		M(1)			7,317	(3)	02/23/2032	Class A Common Stock	7,317	$0	149,313	D
Stock Option (right to buy)	$11.53	01/20/2026		M(1)			1,750	(4)	03/01/2033	Class A Common Stock	1,750	$0	42,996	D

Explanation of Responses:

1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $30.21-$30.44. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

3. The Reporting Person received stock options to purchase shares of Class A Common Stock. The stock options vest over a 4-year period, with 1/48 of the shares vesting when the Reporting Person completes each month of continuous service, beginning March 24, 2022.

4. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe	01/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did HIMS CFO Oluyemi Okupe report on this Form 4?

The CFO reported exercising stock options for 7,317 and 1,750 Class A Common shares on January 20, 2026, followed by a sale of 9,067 Class A Common shares the same day.

At what prices did the HIMS CFO exercise options and sell shares?

Options were exercised at $5.01 and $11.53 per share. The 9,067 shares sold had a weighted average sale price of $30.3423, with individual sales between $30.21 and $30.44.

How many HIMS shares does the CFO own after the reported transactions?

After the transactions, the CFO directly owned 91,617 Class A Common shares and indirectly held 7,853 shares through the Oluyemi Okupe Separate Property Trust dated September 1, 2021.

How many stock options does the HIMS CFO hold following this Form 4?

Following the reported option exercises, the CFO held stock options covering 149,313 and 42,996 Class A Common shares in two separate option grants.

Were the HIMS CFO’s trades made under a Rule 10b5-1 plan?

Yes. The filing states that the option exercises and sales were effected under a Rule 10b5-1 trading plan adopted on May 21, 2025 by the CFO.

What are the vesting terms of the HIMS CFO’s stock options?

One option grant vests over 4 years with 1/48 of the shares vesting monthly starting March 24, 2022. The other also vests over 4 years with 1/48 vesting monthly beginning April 1, 2023.